![]() Proteome Sciences Reaching New Heights in Biomarker Solutions-Protein and peptide biomarker solutions for pharmaceutical and diagnostics applications | ![]() Versantis Versantis is a developer of liver disease therapeutics and diagnostics intended to provide the first drug capture platform for the treatment of life-threatening intoxications. | IMIDomics IMIDomics is a company that develops medicine diagnostics and therapeutics to optimize treatment of IMID (immune-mediated inflammatory diseases) patients. | |
Founding Date | Founding Date N/A | Founding Date 2015 | Founding Date 2015 |
Type | Type Public | Type Private | Type Private |
Tags | |||
Locations | Locations Addlestone, GB HQ Frankfurt Am Main, DE Cobham, GB | Locations Zürich, CH HQ | Locations HQ |
Employees | Employees 363% increase | Employees 2 | Employees 3 |
Funding | |||
Latest funding round | Latest funding round N/A | Latest funding round $ 16.1m (over 6 years ago) | Latest funding round $ 16.5m (almost 5 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 20.7m | Total funding raised $ 16.5m |

Versantis is a developer of liver disease therapeutics and diagnostics intended to provide the first drug capture platform for the treatment of life-threatening intoxications.
View companyIMIDomics is a company that develops medicine diagnostics and therapeutics to optimize treatment of IMID (immune-mediated inflammatory diseases) patients.
View company